Puluo Pharmaceutical Enters into Strategic Cooperation Framework Agreement with Derui Zhiyao for Long-term CDMO Collaboration

Gelonghui January 27 | Proteris Pharmaceutical (000739.SZ) announced that the company has signed a "Strategic Cooperation Framework Agreement" with Hangzhou MindRank Ltd., forming a strategic partnership to carry out long-term cooperation on CDMO projects. This agreement does not involve substantive transactions and does not constitute a related party transaction or a major asset restructuring. It does not have a significant impact on the company's operating performance for the current year, and its impact on the operating performance in future years will depend on the specific project agreements and implementation.